Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Authors
Keywords
Gene expression, Cancer chemotherapy, Breast cancer, Lymphocytes, Histology, Chemotherapy, Cancer treatment, Metastasis
Journal
PLoS One
Volume 11, Issue 6, Pages e0157368
Publisher
Public Library of Science (PLoS)
Online
2016-06-17
DOI
10.1371/journal.pone.0157368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
- (2016) Brian Z. Ring et al. BMC CANCER
- Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
- (2016) Yuka Asano et al. BRITISH JOURNAL OF CANCER
- Immunotherapy Slows TNBC Progression
- (2015) Cancer Discovery
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
- (2014) Ezzeldin M. Ibrahim et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab Shows Potential in Breast Cancer
- (2014) Cancer Discovery
- Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer
- (2013) C. E. Horak et al. CLINICAL CANCER RESEARCH
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of III-Tubulin Expression as a Predictive Marker
- (2013) C. Saura et al. ONCOLOGIST
- GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer
- (2012) Tomohiro Miyake et al. CANCER SCIENCE
- A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
- (2012) Benjamin Haibe-Kains et al. JNCI-Journal of the National Cancer Institute
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
- (2011) Stefan Glück et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
- (2011) Laura J. Esserman et al. BREAST CANCER RESEARCH AND TREATMENT
- Higher population-based incidence rates of triple-negative breast cancer among young African-American women
- (2011) Kathryn C. Amirikia et al. CANCER
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started